Chief Executive Officer at Synlico.
Earliest Form D on file: Feb 2025
Engineered T cell therapies for solid tumors
Biotech, South San Francisco CA
Signed as Chief Executive Officer
$3M
sold of $3M offered
Form D
Browse by sector
Browse by state